The 10 most important advances in cardiovascular medicine during the past 50 years, with apologies to david letterman Joseph S. Alpert Editor’s Commentary Pages: 433 - 435
Should all implantable cardioverter defibrillators for ventricular arhythmias be dual-chamber devices? Kathy L. LeeChu-Pak Lau OriginalPaper Pages: 447 - 450
Transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia Eduardo SosaMauricio ScanavaccaAndré d’Avila OriginalPaper Pages: 451 - 458
Are drugs and catheter ablation effective for treating ventricular arrhythmias in populations that cannot afford implantable cardioverter defibrillators? Kewal K. TalwarNitish NaikRajnish Juneja OriginalPaper Pages: 459 - 466
Algorithms for better arrhythmia discrimination in implantable cardioverter defibrillators Rainer SchimpfChristian WolpertBerndt Lüderitz OriginalPaper Pages: 467 - 472
An evidence-based approach to diagnosing renovascular hypertension Michael J. Bloch OriginalPaper Pages: 477 - 484
Diastolic function in hypertension Robert A. PhillipsJoseph A. Diamond OriginalPaper Pages: 485 - 497
Implications of recent heart failure trials for patients with hypertension Philip A. Poole-Wilson OriginalPaper Pages: 504 - 510
The role of angiotensinconverting enzyme inhibitors in the treatment of hypertension Peter Sleight OriginalPaper Pages: 511 - 518